RE: Hemo Share Price Chart Error26 Jun 2020 16:01
Asleep, I think its going to be a number of rather sharp jump when it happens. So far the RNS's have lacked figures, there have been no big upfront cash payments, no milestone payments detailed, no percentage royalties etc. I would expect the licencing agreement with GlobalCo to include those figures and then we should see a revaluation based on actual and projected revenues.
Also we have not crossed the threshold for many investment groups, even companies like MotleyFool will not assess and run a piece on us until we cross the 50m threshold then they will be chomping at the bit.
I say unfortunately £1.80 as realistically if you took ALL of Hemogenyx products, gave them time to bring all to licencing stage, IE CDX for AML, ALL, HEMO-CAR-T, Mice, everything was ready to licence then based on the target market and that recent Deloitte presentation we could easily be talking £5-7.50 per share.
I just dont see Global Co being willing to wait that long. I just feel they will buy us up when we have a few more agreements signed and before SP is allowed to get too high.